Geron reported $50.18M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 36010M 2788M
Bio Techne TECH:US $ 246.51M 23.1M
Cti Biopharma CTIC:US $ 58.59M 58.59M
Cytokinetics CYTK:US $ 197.08M 54.24M
Esperion Therapeutics ESPR:US $ 258.68M 398K
Exelixis EXEL:US $ 0M 0M
Genmab GEN:DC 356M 7M
Geron GERN:US $ 50.18M 0.35M
Gilead Sciences GILD:US $ 25183M 4M
Macrogenics MGNX:US $ 0 0
Novartis NOVN:VX SF 24373M 150M
Novavax NVAX:US $ 0M 323.46M
Pain Therapeutics PTIE:US $ 0M 0M
Seattle Genetics SGEN:US $ 0M 0M
YTE INCY:US $ 31.38M 0.25M